Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.38 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.38 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 7/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28488195 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL31121686 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL29376558 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL29932678 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1259745 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1259123 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1259494 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL7117447 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1600427 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1259125 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117467589-A | Escherichia coli for efficiently producing 3-fucosyllactose, and construction method and application thereof | 宜兴食品与生物技术研究院有限公司 | 2024-01-30 | — | — | CN | claimed |
| US-12185721-B2 | Glycoside compound of fatty acids, composition comprising it, process for its obtention and methods to apply it on plants or fruits or both at the same time | CONSEJO NACIONAL DE INVESTIGACIONES CIENTÍFICAS Y TÉCNICAS (CONICET) (AR) | 2025-01-07 | — | — | US | disclosed |
| WO-2024185725-A1 | WATER-IN-OIL EMULSION COMPOSITION AND METHOD FOR PRODUCING SAME | 株式会社トクヤマ | 2024-09-12 | — | — | WO | disclosed |
| CN-117467589-B | Escherichia coli for efficiently producing 3-fucosyllactose, and construction method and application thereof | 江苏集萃未来食品技术研究所有限公司 | 2024-07-26 | — | — | CN | disclosed |
| US-20240237645-A1 | GLYCOSIDE COMPOUND OF FATTY ACIDS, COMPOSITION COMPRISING IT, PROCESS FOR ITS OBTENTION AND METHODS TO APPLY IT ON PLANTS OR FRUITS OR BOTH AT THE SAME TIME | CONSEJO NACIONAL DE INVESTIGACIONES CIENTÍFICAS Y TÉCNICAS (CONICET) (AR) | 2024-07-18 | — | — | US | disclosed |
| CN-117467589-A | Escherichia coli for efficiently producing 3-fucosyllactose, and construction method and application thereof | 宜兴食品与生物技术研究院有限公司 | 2024-01-30 | — | — | CN | disclosed |
| US-11627740-B2 | Glycoside compound of fatty acids, composition comprising it, process for its obtention and methods to apply it on plants or fruits or both at the same time | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TÉCNICAS (CONICET) (AR) | 2023-04-18 | — | — | US | disclosed |
| CN-111225744-B | Protein nanopores removal and reinsertion into membranes using osmotic imbalance | 豪夫迈·罗氏有限公司 | 2022-05-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12185721-B2 | Glycoside compound of fatty acids, composition comprising it, process for its obtention and methods to apply it on plants or fruits or both at the same time | B3GNT2, FUT5, FUT6 | CYP2C19 3678/4885HIF1A 468/4885TDP1 3986/4885 |
| US-20240237645-A1 | GLYCOSIDE COMPOUND OF FATTY ACIDS, COMPOSITION COMPRISING IT, PROCESS FOR ITS OBTENTION AND METHODS TO APPLY IT ON PLANTS OR FRUITS OR BOTH AT THE SAME TIME | B3GNT2, FUT5, FUT6 | CYP2C19 3678/4885HIF1A 468/4885TDP1 3986/4885 |
| US-11627740-B2 | Glycoside compound of fatty acids, composition comprising it, process for its obtention and methods to apply it on plants or fruits or both at the same time | B3GNT2, FUT5, FUT6 | CYP2C19 3678/4885HIF1A 468/4885TDP1 3986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.